Valuation: Beijing Airdoc Technology Co., Ltd.

Market Cap 833M 968M 123M 107M 99.7M 91.46M 172M 11.75B 175M 1.17B 459M 5.89B 463M 453M 19.46B P/E 2026 *
-22.1x
P/E 2027 * -408x
Enterprise Value 833M 968M 123M 107M 99.7M 91.46M 172M 11.75B 175M 1.17B 459M 5.89B 463M 453M 19.46B EV / Sales 2026 *
3.31x
EV / Sales 2027 * -
Free-Float
18.83%
Yield 2026 *
-
Yield 2027 * -
1 day-1.90%
1 week-2.31%
Current month-4.81%
1 month-11.67%
3 months-18.33%
6 months-23.63%
Current year-18.55%
1 week 9.31
Extreme 9.31
9.53
1 month 9.15
Extreme 9.15
11.48
Current year 9.15
Extreme 9.15
13.77
1 year 9.15
Extreme 9.15
16
3 years 7.88
Extreme 7.88
18.38
5 years 7.88
Extreme 7.88
74.95
10 years 7.88
Extreme 7.88
74.95
Manager TitleAgeSince
Chief Executive Officer 43 09/09/2015
General Counsel - 01/03/2021
Corporate Secretary - 19/01/2022
Director TitleAgeSince
Chairman 43 09/09/2015
Director/Board Member 63 25/12/2020
Director/Board Member 53 25/12/2020
Date Insider Type Main position Quantity % Market Cap.
1/20/26 A Other

Chief Executive Officer

418,500 0.4041%
9/24/25 A Other

Chief Executive Officer

35,000 0.0338%
9/2/25 A Other

Chief Executive Officer

20,000 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-1.90%-2.31%-28.60%-0.32% 123M
+5.82%+13.10%-18.31%+18.84% 37.44B
+0.30%+7.24%-42.05%+152.52% 12.99B
-0.37%-0.45%-24.03%+62.98% 5.44B
+5.99%+14.23%+0.24% - 2.49B
+3.31%+2.50% - - 1.84B
+1.80%+4.07%+19.40%-43.77% 1.68B
+4.15%+0.58%-32.55% - 1.02B
+1.98%+6.68%+36.18%+128.08% 915M
-1.36%+1.68%-33.39%-47.69% 833M
Average +1.97%+4.45%-13.68%+38.66% 6.48B
Weighted average by Cap. +3.84%+10.08%-21.63%+51.04%

Financials

2026 *2027 *
Net sales 252M 293M 37.34M 32.3M 30.16M 27.67M 52.04M 3.55B 52.87M 354M 139M 1.78B 140M 137M 5.89B -
Net income -39M -45.34M -5.78M -5M -4.67M -4.28M -8.05M -550M -8.18M -54.77M -21.5M -276M -21.7M -21.23M -911M -
Net Debt - -
Logo Beijing Airdoc Technology Co., Ltd.
Beijing Airdoc Technology Co Ltd is a China-based company primarily engaged in providing artificial intelligence (AI)-empowered retina-based early detection, diagnosis and health risk assessment solutions. The Company’s main products include Myopia Prevention and Control AI (PBM-AI), Retinal Detection AI (Retina AI) and Stress Resilience Monitoring AI (Neuro-AI). The Company offers health risk assessment solutions with the ability to detect risk indicators, including risk assessments of retinal abnormalities, retinal vascular diseases, vitreous abnormalities, retinal tumors, optic nerve pathologies, macular diseases, congenital anomalies of the retina, cardiovascular disease and anemia. The Company conducts its business in the domestic and overseas markets.
Employees
181
Date Price Change Volume
10/08/26 HK$9.310 -1.90% 200
07/08/26 HK$9.490 0.00% 0
06/08/26 HK$9.490 -0.42% 0
05/08/26 HK$9.530 0.00% 500
04/08/26 HK$9.530 0.00% 0
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
8.163CNY
Average target price
11.22CNY
Spread / Average Target
+37.43%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2251 Stock